ATE110770T1 - Proliferation von cd4-lymfocyten. - Google Patents

Proliferation von cd4-lymfocyten.

Info

Publication number
ATE110770T1
ATE110770T1 AT90904107T AT90904107T ATE110770T1 AT E110770 T1 ATE110770 T1 AT E110770T1 AT 90904107 T AT90904107 T AT 90904107T AT 90904107 T AT90904107 T AT 90904107T AT E110770 T1 ATE110770 T1 AT E110770T1
Authority
AT
Austria
Prior art keywords
lymphocytes
methyl ester
leucine methyl
alkyl ester
lymfocytes
Prior art date
Application number
AT90904107T
Other languages
English (en)
Inventor
Kam Hung Leung
Robert Martin Townsend
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Application granted granted Critical
Publication of ATE110770T1 publication Critical patent/ATE110770T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/428—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90904107T 1989-02-21 1990-02-08 Proliferation von cd4-lymfocyten. ATE110770T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31342189A 1989-02-21 1989-02-21

Publications (1)

Publication Number Publication Date
ATE110770T1 true ATE110770T1 (de) 1994-09-15

Family

ID=23215624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90904107T ATE110770T1 (de) 1989-02-21 1990-02-08 Proliferation von cd4-lymfocyten.

Country Status (7)

Country Link
EP (1) EP0460065B1 (de)
AT (1) ATE110770T1 (de)
AU (1) AU645488B2 (de)
DE (1) DE69012105T2 (de)
DK (1) DK0460065T3 (de)
HU (1) HU902289D0 (de)
WO (1) WO1990010059A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06505250A (ja) * 1991-01-16 1994-06-16 シェリング・コーポレーション 癌の養子免疫療法におけるインターロイキン−１０の使用
US5374549A (en) * 1991-01-31 1994-12-20 Terumo Corporation Process of enriching adherent CD4+ T cells from monocyte depleted peripheral blood mononuclear cells with interleukin 2 and interleukin 4
DE4410136A1 (de) * 1993-03-31 1994-10-06 Boehringer Mannheim Gmbh Tumorizide T-Lymphozyten
US6652850B1 (en) 1993-09-13 2003-11-25 Aventis Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
US5834441A (en) * 1993-09-13 1998-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral (AAV) liposomes and methods related thereto
WO1996016674A1 (en) * 1994-12-01 1996-06-06 New England Deaconess Hospital Corporation In vitro t-lymphopoiesis system
CN107502589A (zh) * 2017-08-04 2017-12-22 北京世纪劲得生物技术有限公司 一种肿瘤浸润淋巴细胞与单个核细胞共培养方法
IL297751A (en) 2020-04-28 2022-12-01 Lyell Immunopharma Inc Methods for culturing cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849329A (en) * 1986-05-30 1989-07-18 E. I. Du Pont De Nemours And Company Process for preparing lymphokine activated killer cells
SE459008B (sv) * 1986-09-04 1989-05-29 Bioinvent Int Ab Saett att framsstaella humana monoklonala antikroppar
CA1300058C (en) * 1987-01-29 1992-05-05 Joseph D. Irr Process for preparing activated killer cells
US4808151A (en) * 1987-04-27 1989-02-28 E. I. Du Pont De Nemours And Company Simplified method for the preparation of human lymphokine activated killer cells
SE461985B (sv) * 1988-09-13 1990-04-23 Bioinvent Int Ab In vitro immunisering av lymfocytinnehaallande cellpopulationer och materialsats daerfoer

Also Published As

Publication number Publication date
AU645488B2 (en) 1994-01-20
AU5196590A (en) 1990-09-26
DE69012105D1 (en) 1994-10-06
WO1990010059A1 (en) 1990-09-07
EP0460065A1 (de) 1991-12-11
HU902289D0 (en) 1991-11-28
EP0460065B1 (de) 1994-08-31
DE69012105T2 (de) 1994-12-22
DK0460065T3 (da) 1994-09-26

Similar Documents

Publication Publication Date Title
JPS5598118A (en) Preparation of type-2 interferon and drug containing the same
MX9203439A (es) Una citocina mamifera, il-11
DE69330566D1 (de) Steigerung der transplantattoleranz durch schwein cytokine
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
GEP20043390B (en) Notch-Ligand
DK0702560T3 (da) Immunforstærkning ved intermitterende interleukin-2 behandling
ATE110770T1 (de) Proliferation von cd4-lymfocyten.
CA2021500A1 (en) Method for stimulating proliferation of peripheral blood lymphocytes
Merluzzi Comparison of murine lymphokine-activated killer cells, natural killer cells, and cytotoxic T lymphocytes
PL327200A1 (en) Endothelium cells proliferation inhibitor and methods of using same
ES2191065T3 (es) Linfocitos t dirigidos.
AU5957090A (en) Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
EP0483237B1 (de) Schutz zytolytischer aktivität von nk-zellen in peripheren blut-mononuklearzellen
EP0257962A3 (de) Verfahren zur Behandlung von Umkreisblut für die Verbesserung der lymphokinaktivierten Töterzell-Immuntherapie
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
AU6044090A (en) Preparation of human adherent lymphokine-activated killer (a-lak) cells
CA2251889C (en) Process for producing and multiplying lymphocytes
Auberger et al. A chymotryptic-type serine protease is required for IL-2 production by Jurkat T cells
Blomgren et al. Regulation of lymphocyte proliferation by soluble products released by stimulated human lymphocytes
Branch Elizabeth A. Grimm, Anthony A. Rayner¹ and Debra J. Wilson
Wagner et al. Heterogeneity of the signal requirements during the primary activation of resting Lyt-2+ cytotoxic T-lymphocyte (CTL) precursors into clonally developing CTL
van Lochern et al. Epstein—Barr Virus Infection Abrogates the Stimulatory Capacity of Β Cells to a Major Histocompatibility Complex Class-II-Restricted Proliferative T-Cell Clone

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties